Also nice to see the second oldest publicly listed company on the ASX up the top of the register - $11bn Washington H. Soul Pattinson. These guys typically conduct very rigorous DD as are LT insto capital...
As for peer comparison, very cheap for a phase 3 biotech + I like their shorter term strategy to commercialise their molecule as a cosmeceutical product (C. USD multi bn end market without the need for a phase 3 trial to register and sell based on the existing data).
Then we have another multi billion end market subject to successful Phase 3.
Tissue Repair Ltd IPO 2021, page-12
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.30M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 22.0¢ | $8.663K | 39.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15286 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 12.08pm 24/05/2024 (20 minute delay) ? |
| TRP (ASX) Chart |